GRP
KYMR icon

Global Retirement Partners’s Kymera Therapeutics KYMR Stock Holding History

Global Retirement Partners’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.17K Buy
+15
New +$1.01K ﹤0.01% 3859

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Global Retirement Partners's KYMR Position: Q4 2025 in Review

Global Retirement Partners opened a new position in Kymera Therapeutics (KYMR) in Q4 2025: 15 shares worth $1.17K. The stake represents ﹤0.01% of the portfolio and ranks #3859 among its holdings.

254 funds tracked by Wall St. Rank hold KYMR as of Q4 2025.

  • Global Retirement Partners held 15 shares of Kymera Therapeutics worth $1.17K as of Q4 2025.
  • Kymera Therapeutics was a new Global Retirement Partners position in Q4 2025.
  • Kymera Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3859 holding.
  • 254 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.